rs147693556

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_005076.5(CNTN2):​c.1405C>A​(p.Pro469Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00208 in 1,614,168 control chromosomes in the GnomAD database, including 11 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P469S) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0021 ( 11 hom. )

Consequence

CNTN2
NM_005076.5 missense

Scores

1
18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:2

Conservation

PhyloP100: 1.20

Publications

5 publications found
Variant links:
Genes affected
CNTN2 (HGNC:2172): (contactin 2) This gene encodes a member of the contactin family of proteins, part of the immunoglobulin superfamily of cell adhesion molecules. The encoded glycosylphosphatidylinositol (GPI)-anchored neuronal membrane protein plays a role in the proliferation, migration, and axon guidance of neurons of the developing cerebellum. A mutation in this gene may be associated with adult myoclonic epilepsy. [provided by RefSeq, Sep 2016]
CNTN2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • epilepsy, familial adult myoclonic, 5
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • benign adult familial myoclonic epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0072214603).
BP6
Variant 1-205064636-C-A is Benign according to our data. Variant chr1-205064636-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 474462.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00161 (245/152332) while in subpopulation AMR AF = 0.00235 (36/15298). AF 95% confidence interval is 0.00198. There are 0 homozygotes in GnomAd4. There are 105 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 11 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTN2NM_005076.5 linkc.1405C>A p.Pro469Thr missense_variant Exon 12 of 23 ENST00000331830.7 NP_005067.1 Q02246A1ML24A1L3A3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTN2ENST00000331830.7 linkc.1405C>A p.Pro469Thr missense_variant Exon 12 of 23 1 NM_005076.5 ENSP00000330633.4 Q02246

Frequencies

GnomAD3 genomes
AF:
0.00162
AC:
246
AN:
152214
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000217
Gnomad AMI
AF:
0.0263
Gnomad AMR
AF:
0.00236
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.00229
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00177
AC:
444
AN:
251302
AF XY:
0.00190
show subpopulations
Gnomad AFR exome
AF:
0.000308
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.00271
Gnomad OTH exome
AF:
0.000815
GnomAD4 exome
AF:
0.00213
AC:
3116
AN:
1461836
Hom.:
11
Cov.:
32
AF XY:
0.00222
AC XY:
1613
AN XY:
727226
show subpopulations
African (AFR)
AF:
0.000209
AC:
7
AN:
33480
American (AMR)
AF:
0.00152
AC:
68
AN:
44712
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
35
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00188
AC:
162
AN:
86254
European-Finnish (FIN)
AF:
0.0000749
AC:
4
AN:
53418
Middle Eastern (MID)
AF:
0.00676
AC:
39
AN:
5768
European-Non Finnish (NFE)
AF:
0.00238
AC:
2642
AN:
1111976
Other (OTH)
AF:
0.00263
AC:
159
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.482
Heterozygous variant carriers
0
173
345
518
690
863
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
92
184
276
368
460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00161
AC:
245
AN:
152332
Hom.:
0
Cov.:
32
AF XY:
0.00141
AC XY:
105
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.000216
AC:
9
AN:
41572
American (AMR)
AF:
0.00235
AC:
36
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.00228
AC:
155
AN:
68032
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
14
28
41
55
69
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00218
Hom.:
3
Bravo
AF:
0.00184
TwinsUK
AF:
0.00216
AC:
8
ALSPAC
AF:
0.00130
AC:
5
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00209
AC:
18
ExAC
AF:
0.00170
AC:
206
EpiCase
AF:
0.00382
EpiControl
AF:
0.00290

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:3Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Epilepsy, familial adult myoclonic, 5 Uncertain:3Benign:1
Oct 31, 2018
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 19, 2017
Mayo Clinic Laboratories, Mayo Clinic
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 06, 2019
Revvity Omics, Revvity
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

CNTN2-related disorder Benign:1
Apr 11, 2023
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.14
BayesDel_addAF
Benign
-0.44
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
19
DANN
Benign
0.92
DEOGEN2
Benign
0.18
T;T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.17
FATHMM_MKL
Uncertain
0.84
D
LIST_S2
Benign
0.84
.;.;T
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.0072
T;T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.1
L;L;.
PhyloP100
1.2
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.6
.;N;.
REVEL
Benign
0.041
Sift
Benign
0.24
.;T;.
Sift4G
Benign
0.48
.;T;.
Polyphen
0.066
B;B;.
Vest4
0.072
MVP
0.81
MPC
0.52
ClinPred
0.0073
T
GERP RS
3.5
Varity_R
0.072
gMVP
0.46
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs147693556; hg19: chr1-205033764; API